Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: Amplification of interleukin-10

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1196-1203

  Nedialkov, Yuri A ^a,b   Motin, Vladimir L ^a   Brubaker, Robert R ^a  

^a MI 48824 1101 ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HYBRID PROTEIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL VIRULENCE; DOWN REGULATION; GENE INDUCTION; GRAFT REJECTION; GRANULOMATOUS INFLAMMATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SEPTIC SHOCK; YERSINIA PESTIS;

EID: 0030946572     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.4.1196-1203.1997     Document Type: Article

References (70)

1. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029-1032.
2. Anderson, G. W., Jr., S. E. C. Leary, E. D. Williamson, R. C. Titball, S. C. Welkos, P. L. Worsham, and A. M. Freidlander. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64:4580-4585.
3. Auchincloss, H., Jr., and D. H. Sachs. 1989. Transplantation and graft rejection, p. 889-992. In W. E. Paul (ed.). Fundamental immunology, 2nd ed. Raven Press, New York, N.Y.
4. Baeuerie, P. A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
5. Banchereau, J., and M. E. Rybak. 1994. Interleukin-4, p. 100-126. In A. W. Thomson (ed.). The cytokine handbook, 2nd ed. Academic Press, Inc., San Diego, Calif.
6. Bellanti, J. A., J. V. Kadlec, and A. Escobar-Guitiérrez. 1994. Cytokines and the immune response. Clin. Immunol. 41:597-621.
7. Bergman, T., S. Håkansson, Å. Forsberg, L. Norlander, A. Macellaro, A. Backman, and H. Wolf-Watz. 1991. Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J. Bacteriol. 173:1607-1616.
8. Beutler, B. I., W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
9. Bohn, E., and I. B. Autenrieth. 1996. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J. Immunol. 156:1458-1468.
10. Bölin, I., and H. Wolf-Watz. 1988. The virulence plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at transcriptional level. Mol. Microbiol. 2:237-245.
11. Brubaker, R. R., A. K. Sample, D.-Z. Yu, R. J. Zahorchak, P. C. Hu, and J. M. Fowler. 1987. Proteolysis of V antigen from Yersinia pestis. Microb. Pathog. 2:49-62.
12. ++ on lysis, growth, and production of virulence antigens by Pasteurella pestis. J. Infect. Dis. 114:13-25.
13. Burrows, T. W. 1956. An antigen determining virulence in Pasteurella pestis. Nature (London) 177:426-427.
14. Burrows, T. W. 1963. Virulence of Pasteurella pestis and immunity to plague. Ergeb. Mikrobiol. 37:59-113.
15. Burrows, T. W., and G. A. Bacon. 1956. The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br. J. Exp. Pathol. 37:481-493.
16. Capo, C., Y. Zaffron, F. Zugun, P. Houpikian, D. Raoult, and J.-L. Mege. 1996. Production of interleukin-10 and transforming growth factor b by peripheral blood mononuclear cells in Q fever endocarditis. Infect. Immun. 64:4143-4147.
17. Charlton, B., H. Auchinloss, Jr., and C. G. Fathman. 1994. Mechanisms of transplant tolerance. Annu. Rev. Immunol. 12:707-734.
18. Cornelis, G., C. Sluiters, C. Lambert de Rouvroit, and T. Michiels. 1989. Homology between VirF, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J. Bacteriol. 171:254-262.
19. Derynck, R. 1994. Transforming growth factor-beta, p. 319-342. In A. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, Inc., San Diego, Calif.
20. Dinarello, C. A. 1994. Interleukin-1. Adv. Pharmacol. 25:21-51.
21. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence of IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor alpha. J. Immunol. 149:1666-1670.
22. Fernandez-Lago, L., M. Monte, and A. Chordi. 1996. Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice. FEMS Immunol. Med. Microbiol. 15:109-114.
23. Forsberg, A., and H. Wolf-Watz. 1988. The virulence protein Yop5 of Yersinia pseudotuberculosis is regulated at transcriptional level by a repressor and an activator controlled by temperature and calcium. Mol. Microbiol. 2:121-133.
24. Gadina, M., R. Bertini, M. Mengozzi, M. Zandalasini, A. Mantovani, and P. Ghezzi. 1991. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J. Exp. Med. 173:1305-1310.
25. Gérard, C., A. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
26. Haraguchi, S., R. A. Good, M. James-Yarish, and G. J. Cianciolo. 1995. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA 92:3611-3615.
27. Hoe, N. P., and J. D. Goguen. 1993. Temperature sensing in Yersinia pestis: translation of the LcrF activator protein is thermally regulated. J. Bacteriol. 175:7901-7909.
28. Howard, M., T. Muchamuel, and A. Andrade. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
29. Kuby, J. 1994. Immunology, 2nd ed., p. 297-322. W. H. Freeman & Co., New York, N.Y.
30. Lambert de Rouvroit, C., C. Sluiters, and G. R. Cornelis. 1992. Role of the transcriptional activator, VirF, and temperature in the expression of the pYV plasmid genes of Yersinia enterocolitica. Mol. Microbiol. 6:395-409.
31. Lawton, W. D., R. L. Erdman, and M. J. Surgalla. 1963. Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immunol. 91:179-184.
32. Leary, S. E. C., E. D. Williamson, K. F. Griffin, P. Russell, S. M. Eley, and R. W. Titball. 1995. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:2854-2858.
33. Luderitz, O., O. Westphal, A. M. Staub, and H. Nikaido. 1971. Isolation and chemical and immunological characterization of bacterial liposaccharides, p. 145-224. In G. Weinbaum, S. Kadis, and S. J. Ajl (ed.), Microbial toxins, vol. 4. Academic Press, Inc., New York, N.Y.
34. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gérard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
35. Melby, P. C., F. Andrade-Narvaez, B. J. Daenell, and G. Valencia-Pacheco. 1996. In situ expression of interleukin-10 and interieukin-12 in active human cutaneous leishmaniasis. FEMS Immunol. Med. Microbiol. 15:101-107.
36. Mengozzi, M., G. Fantuzzi, R. Faggioni, A. Marchant, M. Goldman, S. Orencole, B. D. Clark, M. Sironi, F. Benigini, and P. Ghezzi. 1994. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82:207-210.
37. Mosmann, T. R. 1994. Interleukin-10, p. 224-237. In A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, Inc., San Diego, Calif.
38. Motin, V. L., S. M. Kutas, and R. R. Brubaker. Suppression of mouse skin allograft rejection by protein A-yersiniae V antigen fusion peptide. Transplantation, in press.
39. Motin, V. L., R. Nakajima, G. B. Smirvov, and R. R. Brubaker. 1994. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62:4192-4201.
40. Motin, V. L., Y. A. Nedialkov, and R. R. Brubaker. 1996. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect. Immun. 64:4313-4318.
41. Nakajima, R., and R. R. Brubaker. 1993. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61:23-31.
42. Nakajima, R., V. L. Motin, and R. R. Brubaker. 1995. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63:3021-3029.
43. Park, D. R., and S. J. Skerrett. 1996. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-γ. J. Immunol. 157:2528-2538.
44. 2+ response operon encodes the V antigen of Yersinia pestis. Infect. Immun. 54:428-134.
45. 2+-response virulence genes in Yersinia pestis. J. Bacteriol. 173:2649-2657.
46. Price, S. B., K. Y. Leung, S. S. Barve, and S. C. Straley. 1989. Molecular analysis of lcrGVH, the V operon of Yersinia pestis. J. Bacteriol. 171:5646-5653.
47. Randow, F., U. Syrbe, C. Meisel, D. Krausch, H. Zuckermann, C. Platzer, and H.-D. Volk. 1995. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J. Exp. Med. 181:1887-1892.
48. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end-points. Am. J. Hyg. 27:493-497.
49. Rosqvist, R., I. Bölin, and H. Wolf-Watz. 1988. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56:2139-2143.
50. Rosqvist, R., Å. Forsberg, M. Rempelainen, T. Bergman, and H. Wolf-Watz. 1990. The cytotoxic YopE of Yersinia obstructs the primary host defense. Mol. Microbiol. 4:657-667.
51. Rosqvist, R., Å. Forsberg, and H. Wolf-Watz. 1991. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59:4562-4569.
52. Schulte, R., P. Wattiau, E. L. Hartland, R. M. Robins-Browne, and G. R. Cornelius. 1996. Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica. Infect. Immun. 64:2106-2113.
53. Sher, A., D. Fiorentino, P. Casper, E. Pearce, and T. Mosmann. 1991. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147:2713-2716.
54. 2+ response, and virulence of Yersinia pestis. J. Bacteriol. 177:2530-2542.
55. Smith, H., J. Keppie, E. C. Cocking, and K. Witt. 1960. The chemical basis of the virulence of Pasteurella pestis. I. The isolation and the aggressive properties of Past, pestis and its products from infected guinea pigs. Br. J. Exp. Pathol. 41:452-459.
56. - Yersinia pestis in BALB/c mice. Infect. Immun. 57:1200-1210.
57. Straley, S. C., E. Skrzypek, G. V. Plano, and J. B. Bliska. 1993. Yops of Yersinia spp. pathogenic to man. Infect. Immun. 61:3505-3510.
58. Tarazona, R., A. González-García, N. Zamzami, P. Marchetti, N. Frechin, J. A. Gonzalo, M. Ruiz-Gayo, N. Van Rooijen, C. Martínez, and G. Kroemer. 1995. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 154:861-870.
59. Tripp, C. T., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725-3729.
60. r phenotypes of yersiniae. Infect. Immun. 43:895-900.
61. Une, T., and R. R. Brubaker. 1984. Roles of V antigen in promoting virulence and immunity in yersiniae. J. Immunol. 133:2226-2230.
62. Une, T., R. Nakajima, and R. R. Brubaker. 1986. Roles of V antigen in promoting virulence in Yersinia. Contrib. Microbiol. Immunol. 9:179-185.
63. van der Poll, T., J. Jansen, M. Levi, H. ten Cate, J. W. ten Cate, and S. J. H. van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1989.
64. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
65. Waage, A., and T. Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J. Exp. Med. 167:1987-1992.
66. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood in mononuclear cells. J. Immunol. 153:811-816.
67. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor kappa B (NK kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558-9563.
68. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853-6861.
69. Wattiau, P., and G. R. Cornelis. 1994. Identification of DNA sequences recognized by VirF, the transcriptional activator of the Yersinia Yop regulon. J. Bacteriol. 176:3878-3884
70. Zanetti, G., D. Heumann, J. Gérain, J. Kohler, P. Abbet, C. Barras, R. Lucas, M.-P. Glauser, and J.-D. Baumgartner. 1992. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide. J. Immunol. 148:1890-1897.